A phase I/II study of concurrent nab-paclitaxel, carboplatin, and IMRT for locally advanced squamous cancer of the head and neck (LASCCHN).
Roy B. Tishler
Research Funding - Celgene
Jochen H. Lorch
No relevant relationships to disclose
David J Sher
No relevant relationships to disclose
John Ross Clark
No relevant relationships to disclose
Annie W Chan
No relevant relationships to disclose
Margaret Suda
No relevant relationships to disclose
Tracy A. Balboni
No relevant relationships to disclose
Paul M. Busse
No relevant relationships to disclose
Robert I. Haddad
Consultant or Advisory Role - Boehringer Ingelheim
Research Funding - AstraZeneca; Sanofi
Lori J. Wirth
No relevant relationships to disclose